News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Fruchtman Steven M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/04/2023 |
4
| Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 4,744 shares
@ $1.01, valued at
$4.8k
Exercised 12,567 restricted stock units
@ $0 |
|
| 03/14/2023 |
4
| Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 207,000 options to buy
@ $0.73, valued at
$151.1k
Granted 69,333 restricted stock units
@ $0 |
|
| 02/08/2023 |
4
| Fruchtman Steven M (PRESIDENT, CHIEF EXECUTIVE OFF) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 6,977 shares
@ $1.36, valued at
$9.5k
Exercised 21,320 restricted stock units
@ $0 |
|
| 08/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/09/2022 |
4
| Fruchtman Steven M (President, Chief Executive Off) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 191,880 options to buy
@ $1.82, valued at
$349.2k
Granted 63,960 restricted stock units
@ $0 |
|
| 09/28/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/20/2020 |
4
| Fruchtman Steven M (President, Chief Executive Off) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Bought 26,800 shares
@ $0.3678, valued at
$9.9k
|
|
| 12/26/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/26/2019 |
4
| Fruchtman Steven M (President, Chief Executive Off) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Bought 149,000 shares
@ $0.2, valued at
$29.8k
Bought 149,000 options to buy
@ $0.2, valued at
$29.8k
|
|
| 07/30/2018 |
4
| Fruchtman Steven M (President, Chief Medical Off) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 400,000 options to buy
@ $0.46, valued at
$184k
|
|
| 01/05/2018 |
4
| Fruchtman Steven M (Chief Medical Officer) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 43,627 options to buy
@ $1.5, valued at
$65.4k
|
|
| 01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/19/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/01/2016 |
4
| Fruchtman Steven M (Chief Medical Officer) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $3.24, valued at
$81k
|
|
| 08/10/2016 |
4
| Fruchtman Steven M (Chief Medical Officer) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Exercised (in-or-at-the-money) 6,276 shares
@ $4.1, valued at
$25.7k
Exercised (in-or-at-the-money) 150 options to buy
@ $4.1, valued at
$615
Exercised (in-or-at-the-money) 4,706 warrants
@ $4.92, valued at
$23.2k
|
|
| 06/30/2016 |
4
| Fruchtman Steven M (Chief Medical Officer) has filed a Form 4 on Onconova Therapeutics, Inc.|
Txns:
| Exercised 100 options to buy
@ $6.5, valued at
$650 |
|
|
|